P U Freda - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P U Freda

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

The Journal of Clinical Endocrinology and Metabolism|October 30, 2008

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trialM Boscaro, W H Ludlam, B Atkinson, et al.

Lancet (London, England)|December 6, 2001

Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistA J van der Lely, R K Hutson, P J Trainer, et al.

The New England Journal of Medicine|April 20, 2000

Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

The Journal of Clinical Endocrinology and Metabolism|October 30, 2008

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trialM Boscaro, W H Ludlam, B Atkinson, et al.

Lancet (London, England)|December 6, 2001

Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistA J van der Lely, R K Hutson, P J Trainer, et al.

The New England Journal of Medicine|April 20, 2000

Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.

Pageof 3